ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

News   Mar 10, 2017 | Original Story from ImmunoMet

 
ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing
 
 
 

RELATED ARTICLES

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

An Orange a Day Keeps Vision Condition Away

News

A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

READ MORE

Availability of Brain Tumor Surgery Dye Increases for NHS Patients

News

A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to the National Institute for Health and Care and Excellence (NICE).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy